When looking at weight loss thresholds, 78% of patients on tirzepatide achieved at least 15% weight loss, compared to 51% with semaglutide
As a results, the total cumulative costs of once-weekly semaglutide were lower while the QALYs gains were higher than sitagliptin over patients lifetimes
Semaglutide activates only GLP-1 receptors, while tirzepatide engages both GLP-1 and GIP receptors, creating a more potent appetite and metabolic signal
Ab Woche 12: Die Wirkung stabilisiert sich
Learn more: Dysesthesia and Wegovy 7.2 mg: What to know about the skin-related side effect More severe side effects and warnings with retatrutide When it comes to retatrutide, dose plays a role in side effects
While headaches are not likely caused by these medications, they can be an indirect result of other documented side effects of these medications